Editorial Standards

cleange examines the safety profiles of ingredients found in personal care, household, and consumer products. Our editorial scope covers the toxicological data, regulatory status, and evidence base behind ingredient safety claims — providing readers with the factual foundation needed to evaluate product compositions independently.

The consumer product space is saturated with marketing language designed to trigger emotional responses. Terms like "clean," "natural," "toxic-free," and "chemical-free" convey sentiment but communicate very little about actual safety profiles. Our editorial position is that ingredient safety is a scientific question — answerable with data from toxicological studies, regulatory assessments, and exposure calculations — not a branding exercise.

Every ingredient analysis we publish follows a structured evaluation framework. We document the compound's identity (INCI name, CAS number, chemical class), its function in product formulations, the available toxicological data (acute toxicity, chronic exposure studies, sensitization data, reproductive toxicity assessments where available), its regulatory status across major jurisdictions (FDA, EU Cosmetics Regulation, Health Canada, TGA), and the concentration thresholds at which safety concerns are supported by evidence.

Regulatory threshold documentation is a core editorial function. The same ingredient may be permitted at 0.5% concentration in the EU, 1.0% in the US, and banned entirely in Japan. These differences reflect different risk assessment methodologies, different exposure models, and sometimes different political considerations. Our content documents these thresholds without editorializing about which regulatory approach is correct.

Ingredient interaction analysis addresses the combinations that create safety considerations beyond what individual ingredient profiles suggest. Certain preservative systems produce formaldehyde-releasing compounds under specific pH conditions. Some UV filter combinations degrade each other's efficacy. Our content documents these interactions with the conditions under which they occur and the concentrations at which they become relevant.

Our safety database coverage tracks the authoritative sources that inform ingredient evaluation: the CIR (Cosmetic Ingredient Review) assessments, SCCS (Scientific Committee on Consumer Safety) opinions, ECHA registrations, and the published literature that forms the evidence base for safety conclusions. We document which sources support which conclusions and where the evidence is contested or insufficient.

Our editorial output covers four primary areas:

Toxicology Data and Safety Profiles — Ingredient-level analysis presenting the available toxicological evidence. Each profile covers acute and chronic toxicity data, sensitization and irritation potential, penetration and absorption data where available, and the dose-response relationships that define safe exposure levels. We distinguish between findings from in vitro studies, animal models, and human clinical data, noting the limitations of each evidence type.

Regulatory Thresholds and Status — Documentation of how major regulatory bodies classify and restrict specific ingredients. Coverage includes maximum permitted concentrations, required warnings, restricted product categories, and the regulatory rationale behind each decision. We track regulatory changes and update content when thresholds are revised.

Ingredient Interactions — Analysis of how ingredient combinations affect safety and efficacy. This includes pH-dependent reactions, photostability interactions, preservative system compatibility, and the conditions under which otherwise safe ingredients produce concerning compounds. Each interaction analysis specifies the concentration ranges and conditions under which the interaction occurs.

Safety Database Navigation — Guidance on interpreting the authoritative sources used in ingredient safety evaluation. We explain how to read CIR final reports, interpret SCCS opinions, navigate ECHA's registered substance database, and evaluate the quality of evidence cited in safety assessments. This content helps readers develop independent evaluation capabilities.

Our editorial scope has firm boundaries:

Product endorsements — We do not recommend, endorse, or rank specific consumer products. Our analysis operates at the ingredient level, not the brand level. Readers will not find "best of" lists or product recommendations in our editorial output.

Brand comparisons — We do not compare brands against each other. When multiple products contain the same ingredient, our analysis covers the ingredient — not the companies that use it.

Wellness trends — We do not cover wellness movements, lifestyle trends, or health philosophies. Our scope is limited to the scientific evidence for ingredient safety. We do not evaluate detox protocols, clean living programs, or holistic health frameworks.

Editorial decisions at cleange require that every safety claim be traceable to a specific data source. An article stating that an ingredient "is safe at concentrations below 1%" must cite the study, assessment, or regulatory determination that supports that threshold. Unsourced safety claims are not published.

We apply a neutrality standard to all ingredient coverage. Our content does not advocate for or against specific ingredients. We present the available evidence, note where it is strong, and flag where it is insufficient. The reader draws the conclusion — we provide the data.

When toxicological evidence is conflicting — one study finds no adverse effects while another reports sensitization at the same concentration — we document both findings, note the methodological differences that may explain the discrepancy, and state the current regulatory position. We do not cherry-pick studies to support a predetermined conclusion.

Content updates are triggered by new regulatory actions, significant new toxicological studies, or corrections to previously published data. We do not update articles merely to refresh publication dates.